Ascentage Pharma Group International (OTCMKTS:ASPHF – Get Free Report) was the recipient of a large increase in short interest in the month of June. As of June 30th, there was short interest totaling 541,300 shares, an increase of 213.3% from the June 15th total of 172,800 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.
Ascentage Pharma Group International Stock Performance
ASPHF opened at $4.53 on Wednesday. Ascentage Pharma Group International has a one year low of $4.53 and a one year high of $5.05. The company has a fifty day moving average price of $5.22 and a 200-day moving average price of $7.33.
About Ascentage Pharma Group International
Ascentage Pharma Group International (OTCMKTS:ASPHF) is a clinical-stage biopharmaceutical company headquartered in Beijing, China, with a strategic presence in the United States. The company focuses on the discovery and development of targeted small-molecule therapies that modulate programmed cell death, leveraging a deep understanding of the Bcl-2 family of proteins.
Ascentage’s core activities center on the research and development of apoptosis regulators, including both Bcl-2 selective and dual Bcl-2/Bcl-xL inhibitors.
Featured Stories
- Five stocks we like better than Ascentage Pharma Group International
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
- 3 Overlooked Energy ETFs Delivering Strong Returns and Income
- 3 Space Stocks That Could Outshine SpaceX After Its IPO
- JPMorgan’s Q2 Strength Gives the Stock Rally New Support
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
